Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Share News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Yourgene surges on takeover by Novacyt

Mon, 03rd Jul 2023 10:48

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Yourgene Health PLC, more than doubled to 0.47 pence from 0.20p at Friday's market close, 12-month range 0.12p-8.00p. Shares in the medical diagnostics company rocket as it agrees to a takeover offer from Novacyt SA at 0.522 pence per share in cash. The deal values Yourgene's equity at GBP16.7 million. The companies say the acquisition "strongly aligns" with Novacyt's post-Covid strategy, which included pursuing strategic mergers and acquisitions to support its long-term growth and prioritised the twin objectives of geographic expansion and portfolio development. Shares in Novacyt, a fellow AIM listing, jump 24%.

----------

Verici Dx PLC, up 11% at 13.0p, 12-month range 4.53p-19p. The Cardiff, Wales-based developer of clinical diagnostics for organ transplants receives successful results from its clinical study of Clarava that demonstrate it as a test capable of informing a clear, actionable response from clinicians. Clarava is the company's pre-transplant prognostic test to allow measurement of a patient's immune response to assess the risk of early kidney graft rejection, which could assist an estimated 65,000 patients. Verici Dx says it is on track to launch Clarava commercially in the US before the end of 2023.

----------

AIM - LOSERS

----------

Zanaga Iron Ore Co Ltd, down 22% at 9.75p, 12-month range 1.7p-18.9p. The iron explorer focused on the Republic of the Congo enters into an equity subscription agreement with institutional investor Shard Merchant Capital Ltd. Zanaga will issue up to 36 million shares in up to three tranches of 12 million each. At the current price, the shares will be worth GBP3.7 million in total. Also on Monday, Zanaga reports it swung to a pretax profit in 2022 of USD8.1 million from a loss of USD1.9 million the year before. It generated no revenue, unchanged from a year prior, but reports a USD9.1 million gain on the revaluation of investment.

----------

Kibo Energy PLC, down 12% at 0.05p, 12-month range 0.05p-0.22p. The energy projects in Africa and UK says all funding activities, including the company's proposed AIM-listed vehicle Ultimate Sustainable Energy, have been placed on hold due to delays as a result of "difficulties" at its extraordinary general meeting. Early last month, Kibo reported that five of a total of eight resolutions failed to reach the minimum threshold of 75% of the vote at an EGM. These include equity securities allotment, amendment of the Memorandum of Association and amendment of the Articles of Association. It said back then that 35% of shareholders voted against these resolutions. On Thursday last week, Kibo said it sought funding to address a liquidity crunch. It said liquidity constraints resulted from the "significant" capital required to develop its projects.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
10 Mar 2020 15:31

Yourgene Health acquires its French distribution partner

(Sharecast News) - Molecular diagnostics company Yourgene Health announced the acquisition of AGX-DPNI on Tuesday, which it described as a newly-formed entity comprising the NIPT distribution business of AdGeniX - its current French distribution partner for the 'IONA' test.

Read more
17 Feb 2020 12:49

Yourgene Health Takes Another Step Towards IONA CE Marking Certificate

Yourgene Health Takes Another Step Towards IONA CE Marking Certificate

Read more
17 Feb 2020 08:45

Yourgene submits CE-mark file for 'IONA' test

(Sharecast News) - Molecular diagnostics company Yourgene Health has submitted its CE-marking technical file for the Illumina-based 'IONA' test to its EU notified body, BSI Netherlands, it announced on Monday.

Read more
14 Feb 2020 14:47

Yourgene's 'Elucigene DPYD' approved for sale in Australia

(Sharecast News) - Molecular diagnostics company Yourgene Health announced on Friday that its chemotoxicity diagnostics assay, 'Elucigene DPYD', which tests to identify cancer patients at risk of lethal side effects from chemotherapy, has been approved for sale in Australia by the country's Therapeutic Goods Administration (TGA), as an in vitro diagnostic (IVD).

Read more
14 Feb 2020 09:44

Yourgene Health Says Cancer Test Elucigene Approved In Australia

Yourgene Health Says Cancer Test Elucigene Approved In Australia

Read more
2 Dec 2019 11:55

Yourgene Health Reports "Strong Growth", Supported By New Acquisition

Yourgene Health Reports "Strong Growth", Supported By New Acquisition

Read more
25 Nov 2019 15:57

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
14 Nov 2019 15:05

Concepta Hires BBI Healthcare Director As New Chief Executive Officer

Concepta Hires BBI Healthcare Director As New Chief Executive Officer

Read more
14 Oct 2019 09:08

Yourgene Health Revenue Doubles In First Half On International Growth

Yourgene Health Revenue Doubles In First Half On International Growth

Read more
14 Oct 2019 08:50

Yourgene Health revenues almost double during H1

(Sharecast News) - Molecular diagnostics company Yourgene Health saw top-line growth over the six months ended 30 September as international revenues continued to show "very strong momentum".

Read more
26 Sep 2019 13:24

Yourgene Health Transfers To Netherlands Notified Body Ahead Of Brexit

Yourgene Health Transfers To Netherlands Notified Body Ahead Of Brexit

Read more
17 Sep 2019 13:04

Yourgene Health On Schedule For New Prenatal And Oncology Tests

(Alliance News) - Yourgene Health PLC on Tuesday said it is on track to launch its new non-invasive prenatal test on the Illumina platform in early 2020.YourGene and Illumina agreed to a in

Read more
17 Sep 2019 10:05

Yourgene Health builds 'strong foundation' following 'transformational' period

(Sharecast News) - Molecular diagnostics group Yourgene Health told investors at its annual general meeting on Tuesday that it had built a "strong foundation" following a period of "transformational change".

Read more
16 Aug 2019 12:52

Yourgene Health Appoints Former Roche Diagnostics Director As Non-Exec

(Alliance News) - Yourgene Health PLC on Friday said it appointed Jonathan Seaton as a non-executive director, with immediate effect.The molecular diagnostics company said Seaton has for at

Read more
29 Jul 2019 11:50

Yourgene Health Appoints John Brown As Non-Executive Director

LONDON (Alliance News) - Yourgene Health PLC, which develops treatment for Down's syndrome and other genetic disorders, said Monday that it has appointed John Brown as non-executive director -

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.